Depressive Disorders - Egypt | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$182.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.03%, resulting in a market volume of US$202.20m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$31.30 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Egypt is experiencing significant growth and development, driven by several key factors.

Customer preferences: In Egypt, there is a growing awareness and understanding of mental health issues, including depressive disorders. As a result, there is an increasing demand for effective treatments and therapies for depression. Customers are seeking out a range of options, from pharmaceutical medications to psychotherapy and alternative therapies. This preference for a holistic approach to treating depressive disorders is driving the market forward.

Trends in the market: One of the key trends in the Depressive Disorders market in Egypt is the rising use of antidepressant medications. As more people seek treatment for depression, there is a growing demand for pharmaceutical solutions. This trend is further fueled by the availability of a wider range of antidepressant medications in the market, providing customers with more options to choose from. Additionally, there is a growing trend towards the use of psychotherapy as a complementary treatment to medication, as customers recognize the importance of addressing both the biological and psychological aspects of depression.

Local special circumstances: Egypt has a relatively high prevalence of depressive disorders, which contributes to the growth of the market. The country faces various social and economic challenges, such as high unemployment rates and political instability, which can contribute to higher levels of stress and depression among the population. The cultural stigma surrounding mental health issues is also starting to diminish, leading to increased acceptance and willingness to seek treatment for depressive disorders.

Underlying macroeconomic factors: The growing Depressive Disorders market in Egypt is also influenced by several macroeconomic factors. The country has been experiencing steady economic growth in recent years, leading to an increase in disposable income and healthcare expenditure. This allows individuals to afford the cost of treatment for depressive disorders, including medication and therapy. Furthermore, the government has been taking steps to improve access to mental healthcare services, including the integration of mental health into primary care and the expansion of mental health facilities across the country. These initiatives have helped to increase the availability and accessibility of treatment options for depressive disorders, further driving the growth of the market.In conclusion, the Depressive Disorders market in Egypt is experiencing significant growth and development, driven by increasing customer awareness and demand for effective treatments. The market is characterized by a preference for a holistic approach to treating depressive disorders, with customers seeking out a range of options including medication and psychotherapy. The local special circumstances, such as a high prevalence of depressive disorders and a diminishing cultural stigma, contribute to the growth of the market. Additionally, underlying macroeconomic factors such as economic growth and government initiatives to improve access to mental healthcare services further drive the development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.